BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22745981)

  • 21. [Psoriatic arthritis: what the dermatologist needs to know, Part 2].
    López-Ferrer A; Torrente-Segarra V; Puig L
    Actas Dermosifiliogr; 2010 Nov; 101(9):742-8. PubMed ID: 21034704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of psoriatic arthritis and inflammatory spondylitis.
    Castro-Rueda H; Kavanaugh A
    Curr Pain Headache Rep; 2008 Dec; 12(6):412-7. PubMed ID: 18973733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Problems in psoriatic rheumatism in 1996].
    Kahn MF
    Schweiz Med Wochenschr Suppl; 1996; 80():5S. PubMed ID: 8830401
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging drugs for psoriatic arthritis.
    Olivieri I; D'Angelo S; Palazzi C; Lubrano E; Leccese P
    Expert Opin Emerg Drugs; 2010 Sep; 15(3):399-414. PubMed ID: 20528612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psoriatic arthritis: a review.
    Amherd-Hoekstra A; Näher H; Lorenz HM; Enk AH
    J Dtsch Dermatol Ges; 2010 May; 8(5):332-9. PubMed ID: 20015187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets.
    Kerschbaumer A; Fenzl KH; Erlacher L; Aletaha D
    Wien Klin Wochenschr; 2016 Nov; 128(21-22):791-795. PubMed ID: 27822746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of enthesitis in psoriatic arthritis.
    Kumar N; Kay LJ; Walker DJ
    J Rheumatol; 2004 Nov; 31(11):2311-2; author reply 2312-3. PubMed ID: 15536671
    [No Abstract]   [Full Text] [Related]  

  • 28. Apremilast for the treatment of psoriatic arthritis.
    Martin BC; Thomas LW; Dann FJ
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [TNF-alpha inhibitors].
    Fain O
    Rev Prat; 2003 Nov; 53(18):1989-90. PubMed ID: 15008210
    [No Abstract]   [Full Text] [Related]  

  • 30. Psoriatic arthritis. Is something changing?
    Scarpa R
    Adv Exp Med Biol; 1999; 455():207-14. PubMed ID: 10599345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current status of basic antirheumatic therapy].
    Keitel W
    Fortschr Med; 1994 Oct; 112(30):419-22. PubMed ID: 7806117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of etanercept as a non-surgical treatment for temporomandibular joint psoriatric arthritis: a case report.
    Lamazza L; Guerra F; Pezza M; Messina AM; Galluccio A; Spink M; De Biase A
    Aust Dent J; 2009 Jun; 54(2):161-5. PubMed ID: 19473159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study.
    Bongartz T; Coras B; Vogt T; Schölmerich J; Müller-Ladner U
    Rheumatology (Oxford); 2005 Jan; 44(1):126-9. PubMed ID: 15479756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic arthritis: biologics seen as new treatment. More aggressive treatment is recommended for psoriatic arthritis, a severe, progressive form of the disease.
    Duke Med Health News; 2012 Apr; 18(4):7. PubMed ID: 22545278
    [No Abstract]   [Full Text] [Related]  

  • 35. Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil.
    Madland TM; Björkkjaer T; Brunborg LA; Fröyland L; Berstad A; Brun JG
    J Rheumatol; 2006 Feb; 33(2):307-10. PubMed ID: 16465662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimal important difference and responsiveness to change of the SF-36 in patients with psoriatic arthritis receiving tumor necrosis factor-α blockers.
    Leung YY; Zhu TY; Tam LS; Kun EW; Li EK
    J Rheumatol; 2011 Sep; 38(9):2077-9. PubMed ID: 21885524
    [No Abstract]   [Full Text] [Related]  

  • 38. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving recognition of psoriatic arthritis.
    Conaghan PG; Coates LC
    Practitioner; 2009 Dec; 253(1724):15-8, 2-3. PubMed ID: 20120827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marine oils for antiinflammatory effect -- time to take stock.
    Cleland LG; James MJ
    J Rheumatol; 2006 Feb; 33(2):207-9. PubMed ID: 16465648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.